课题基金 / 基金详情

CANCER CELL BIOLOGY

CANCER CELL BIOLOGY
癌细胞生物学
批准号:
8512126
负责人:
ERWIN G VAN MEIR
金额:
$3.02万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2012
资助国家:
美国
项目状态:
已结题
起止时间:
2012-08-01 至 2017-03-31
关键词:
Abnormal CellAdhesionsAnimal ModelAntineoplastic AgentsAreaBasic ScienceBiologicalBiological MarkersBiological ProcessBlood VesselsBrain NeoplasmsCancer BiologyCancer Center Support GrantCancer ControlCancer PatientCell AdhesionCell CommunicationCell DeathCell ProliferationCell SurvivalCellsCellular biologyCessation of lifeClinicalClinical Trials DesignCollaborationsCombined Modality TherapyCommunicationComputer SimulationDetectionDevelopmentDevelopmental Therapeutics ProgramDiagnosisDirect CostsDisciplineDisorder by SiteDistantDoctor of PhilosophyElementsEndotheliumEpigenetic ProcessEventFeedsFibroblastsFoundationsFundingGene Expression ProfileGene MutationGoalsGrantHumanImageImmuneImpact evaluationInfluentialsInstitutesInstructionInvestigationJournalsLeadLinkMalignant NeoplasmsMediator of activation proteinMetabolismMolecularMutationNeoplasm MetastasisOutcomePathway interactionsPeer ReviewPhenotypePhysiologicalPlant RootsPrimary NeoplasmProcessProductivityProteomePublic HealthPublicationsPublishingResearchResearch PersonnelResearch Project GrantsScienceScientistSignal PathwaySignal TransductionSignal Transduction PathwaySiteSmooth MuscleStem cellsStromal CellsTestingTherapeuticTherapeutic AgentsTissuesTranslatingUniversitiesValidationVertebral columnWorkanticancer researchbonecancer cellcancer diagnosiscancer geneticscancer preventioncancer stem cellcancer typecell behaviorcell motilitycell transformationclinical applicationcohesioncollegedesigndrug developmentfollow-upimaging modalityimprovedknowledge basemedical schoolsmembermolecular imagingneoplastic cellnew therapeutic targetnoveloutcome forecastpre-clinicalprogramsresearch clinical testingresponsestemsuccesstranslational studytumortumor growth

项目摘要

项目成果

ERWIN G VAN MEIR的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY The Winship Cancer Institute's Cancer Cell Biology (CCB) Program studies the changes in biological function of human cells as a result of cell transformation. The CCB Program consists of 36 core members from 15 departments across Emory University, including the Schools of Medicine and Public Health and Emory College. The CCB program has two main themes: 1) Cell Survival and Death Mechanisms, and 2) Cell Adhesion, Communication and Metastasis. The CCB Program serves as Winship's scientific switchboard, a platform for discovery of novel signaling pathways, their biological validation, and an interchange of concepts among the CGE, DDT, and CPC Programs. Strategic reorganization toward increased cohesion and clarity has helped make the current project period a highly productive one for the CCB Program. CCB labs identified and targeted key molecular pathways involved in a variety of disease site-specific cancers. Its members published 300 cancer-related publications, many of which appeared in high-impact journals. The program furthered important initiatives, including the establishment of the In Silico Brain Tumor Research Center. Using start-up funding from internal pilot grants, CCB members expanded pilot science into nationally funded projects. CCB Program members currently have $23,452,748 in research grant funding (annual direct costs), of which $19,909,676 is peer-reviewed and $9,489,373 is NCI funded. As Winship's platform for scientific exchange, the CCB Program's productivity has been a win for all of the research programs and has spurred important inter-programmatic collaborations. The program has published 300 cancer-related publications in the current project period, most of which appeared in influential journals. Among these, approximately or neariy 15% represent intra-programmatic and 38% represent inter-programmatic interactions. CCB members and collaborators have contributed to the field of cancer research in a number of significant ways, and the program is poised for continued success going into the next project period.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mechanisms underlying BAI1/ADGRB1 negative regulation of glioblastoma mesenchymal transition and invasion.
Mechanisms underlying BAI1/ADGRB1 negative regulation of glioblastoma mesenchymal transition and invasion.
Mechanisms underlying BAI1/ADGRB1 negative regulation of glioblastoma mesenchymal transition and invasion.
Targeting Mechanisms of Medulloblastoma Formation
海外基金